* Pfizer’s Sutent helps patients after kidney cancer surgery
(Adds Exelixis planning to seek approval based on study
results)
The post UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial appeared first on NASDAQ.
UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial
